Description
1. GHRP-6 belongs to the category of Growth Hormone Releasing Peptides (GHRP).
2. GHRP-6 functions by stimulating the release of growth hormone in the body.
Additional Info
Properties
- GHRP-6 Chemical Formula: C46H56N12O6
- GHRP-6 Molecular Weight: 873.032 g/mol
- GHRP-6 Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys
- Total Amount of the Active Ingredient: 10mg (1 vial)
- Shelf Life: 36 months
Shipping
Available to USA and Canada. For international orders, if your shipment is seized, contact us for a 50% discount on your next purchase.
Disclaimer
The information provided does not substitute medical advice, diagnosis, or treatment. For medical concerns, consult your physician or qualified healthcare provider promptly. Do not delay medical advice based on information seen or read. We take no responsibility or liability for the use of our research compounds and products. These products are sold exclusively for research purposes and are not intended for personal use.
Additional Label & Product Information
Essential Warning:
These chemicals are strictly for research or laboratory use and are not FDA-approved for human consumption.
Usage Instructions:
- Avoid skin and eye contact; if contact occurs, rinse thoroughly with water.
- Seek medical attention if feeling unwell or in case of accidental ingestion.
- Store the lyophilized (freeze-dried) peptide at room temperature immediately upon receipt to maintain stability.
- Avoid repeated freeze-thaw cycles to preserve peptide integrity.
Product Disclaimer:
This product is not meant to diagnose, treat, cure, or prevent any disease. Use strictly according to your specific research or laboratory protocol.
Resources
- Subirós N, Pérez-Saad HM, Berlanga JA, Aldana L, García-Illera G, Gibson CL, García-Del-Barco D. Evaluation of dose-response relationship and therapeutic window in animal studies investigating coadministration of rhEGF and GHRP-6 for stroke treatment. Neurol Res. 2016 Mar;38(3):187-95. doi: 10.1179/1743132815Y.0000000089. Epub 2016 Apr 19. PMID: 26311576.
- Suda Y, Kuzumaki N, Sone T, Narita M, Tanaka K, Hamada Y, Iwasawa C, Shibasaki M, Maekawa A, Matsuo M, Akamatsu W, Hattori N, Okano H, Narita M. Reduction of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to motor dysfunction resembling Parkinson’s disease. Mol Brain. 2018 Feb 20;11(1):6. doi: 10.1186/s13041-018-0349-8. PMID: 29458391; PMCID: PMC5819262.
- Berlanga J, Cibrian D, Guevara L, Dominguez H, Alba JS, Seralena A, Guillén G, López-Mola E, López-Saura P, Rodriguez A, Perez B, Garcia D, Vispo NS. Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidative damage and reduces myocardial cell death in an acute myocardial infarction model. Clin Sci (Lond). 2007 Feb;112(4):241-50. doi: 10.1042/CS20060103. PMID: 16989643.
- Huang HJ, Zhu XC, Han QQ, Wang YL, Yue N, Wang J, Yu R, Li B, Wu GC, Liu Q, Yu J. Ghrelin mitigates anxiety- and depression-like behaviors induced by chronic unpredictable mild stress in rodents. Behav Brain Res. 2017 May 30;326:33-43. doi: 10.1016/j.bbr.2017.02.040. Epub 2017 Feb 27. PMID: 28245976.
- Berlanga-Acosta J, Abreu-Cruz A, Herrera DGB, Mendoza-Marí Y, Rodríguez-Ulloa A, García-Ojalvo A, Falcón-Cama V, Hernández-Bernal F, Beichen Q, Guillén-Nieto G. Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Critical Review of the Evidence Supporting Their Protective Effects on Cells. Clin Med Insights Cardiol. 2017 Mar 2;11:1179546817694558. doi: 10.1177/1179546817694558. PMID: 28469491; PMCID: PMC5392015.
Reviews
There are no reviews yet.